Similar articles

• Pantethine treatment is effective in recovering the disease phenotype induced by ketogenic diet in a pantothenate kinase-associated neurodegeneration mouse model.

  Brunetti D, Dusi S, Giordano C, Lamperti C, Morbin M, Fugnanesi V, Marchet S, Fagiolari G, Sibon O, Moggio M, d'Amati G, Tiranti V. Brunetti D, et al. Brain. 2014 Jan;137(Pt 1):57-68. doi: 10.1093/brain/awt325. Epub 2013 Dec 6. Brain. 2014. PMID: 24316510 Free PMC article.
• A novel mutation in a patient with pantothenate kinase-associated neurodegeneration.

  Saleheen D, Nazir A, Khanum S, Haider SR, Frossard P. Saleheen D, et al. CMAJ. 2005 Sep 13;173(6):578-9. doi: 10.1503/cmaj.1050096. CMAJ. 2005. PMID: 16157712 Free PMC article. No abstract available.
• Pantothenate kinase-associated neurodegeneration (formerly Hallervorden-Spatz syndrome).

  Hayflick SJ. Hayflick SJ. J Neurol Sci. 2003 Mar 15;207(1-2):106-7. doi: 10.1016/s0022-510x(02)00433-1. J Neurol Sci. 2003. PMID: 12614941 Review. No abstract available.
• Acetyl-4'-phosphopantetheine is stable in serum and prevents phenotypes induced by pantothenate kinase deficiency.

  Di Meo I, Colombelli C, Srinivasan B, de Villiers M, Hamada J, Jeong SY, Fox R, Woltjer RL, Tepper PG, Lahaye LL, Rizzetto E, Harrs CH, de Boer T, van der Zwaag M, Jenko B, Čusak A, Pahor J, Kosec G, Grzeschik NA, Hayflick SJ, Tiranti V, Sibon OCM. Di Meo I, et al. Sci Rep. 2017 Sep 12;7(1):11260. doi: 10.1038/s41598-017-11564-8. Sci Rep. 2017. PMID: 28900161 Free PMC article.
• Neurological disorders associated with DNA strand-break processing enzymes.

  Jiang B, Glover JN, Weinfeld M. Jiang B, et al. Mech Ageing Dev. 2017 Jan;161(Pt A):130-140. doi: 10.1016/j.mad.2016.07.009. Epub 2016 Jul 25. Mech Ageing Dev. 2017. PMID: 27470939 Free PMC article. Review.